Fatal exacerbation of ChadOx1-nCoV-19-induced thrombotic thrombocytopenia syndrome after initial successful therapy with intravenous immunoglobulins - a rational for monitoring immunoglobulin G levels.

Haematologica

Université catholique de Louvain, CHU UCL Namur, Namur Thrombosis and Hemostasis Center, Hematology Laboratory, Namur Research Institute for Life Sciences, Yvoir.

Published: December 2021

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634183	PMC
http://dx.doi.org/10.3324/haematol.2021.279509	DOI Listing

Publication Analysis

fatal exacerbation

exacerbation chadox1-ncov-19-induced

chadox1-ncov-19-induced thrombotic

thrombotic thrombocytopenia

thrombocytopenia syndrome

syndrome initial

initial successful

successful therapy

therapy intravenous

intravenous immunoglobulins

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!